CompletedNot Applicable

Interstitial Lung Disease is a Risk Factor for Cardiovascular Disease

Egypt134 participantsStarted 2023-09-01

Plain-language summary

A group of Interstitial pulmonary fibrosis will be recruited from Assiut university hospital outpatient clinic. Evaluation will be done regarding cardiovascular comorbidities (Cardiovascular comorbidities will be evaluated with thorough assessment including; history, ECG, Lipid profile and echocardiography). Lipid profile, CRP and KL-6 level will be assessed for recruited personnel. Regression analysis will be used to identify risk factors for cardiovascular comorbidities among IPF patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed as Interstitial pulmonary fibrosis Exclusion Criteria: * Patients refusing to participate in the study

What they're measuring

percentage of patients with IPF who develop cardiovascular comorbidities

Timeframe: 6 months

Trial details

NCT IDNCT06539962

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More Interstitial Lung Disease trials